Lyndra Therapeutics®, a clinical-stage biopharmaceutical company pioneering long-acting oral therapies, today announced the ...

The LYNX technology originated in the Traverso and Langer Laboratories at MIT, with which Lyndra has an exclusive technology ...

Long-acting risperidone is a suspension administered by intramuscular injection in the upper-outer gluteal area. It consists of risperidone impregnated in microspheres composed of a biodegradable ...

The introduction of a new psychopharmaceutical medication instead of the previous one always poses a certain challenge. In the case of antipsychotics (AP), these problems are considerably more ...

Risperidone is also a potent antagonist at 5-hydroxytryptamine type 2 (5-HT 2) receptors. This may result in a reduced propensity to cause EPSs. [7,27] Risperidone has a high affinity for both 5 ...